Primary Percutaneous Coronary Intervention Clinical Trial
Official title:
Influence Of Incomplete Revascularization on Long-Term Outcomes After Primary Percutaneous Coronary Intervention (PPCI). A Single Center Real-Life Retrospective Analysis
evaluate the influence of incomplete revascularization during the index hospitalization on in-hospital and long-term outcomes in STEMI patients undergoing PPCI in Assiut University heart hospital.
- Study groups: Patients will be divided into 2 groups
1. Group I: Complete revascularization was achieved by PPCI.
2. Group II: Complete revascularization was not achieved by PPCI.
- In hospital outcomes: All the patients will be reviewed for during hospital admission to
record major acute cardiac events (MACE). Only the most serious event of major adverse
cardiac events will be used to calculate the cumulative major adverse cardiac events per
patient according to the following sequence: (death > heart failure > recurrent
non-fatal MI > serious secondary arrhythmia necessitating DC shock> recurrent or
refractory angina. MACE will be reported according to the standard definitions.(Tsai IT,
et al.,2017)
- Long-term follow-up: The patients will be followed by telephone interviews for all-cause
mortality, re-hospitalization by ACS, re-hospitalization by heart failure, planned and
unplanned PCI or CABG. Long-term MACE will include: all-cause mortality,
re-hospitalization by ACS, re-hospitalization by heart failure, unplanned
revascularization. Patients who undergo planned revascularization later on after
discharge will be followed till the date of revascularization for actual events and will
be censored in Kaplan Meier Survival analysis. These patients will be included in a
third group of staged late complete revascularization to be followed for the long-term
MACE events starting from the planned revascularization procedure.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02023983 -
Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction
|
N/A | |
| Recruiting |
NCT01860079 -
Early Discharge After Primary Percutaneous Coronary Intervention
|
N/A | |
| Completed |
NCT01152138 -
Closed Versus Open Cells Stent for Acute Myocardial Infarction
|
N/A | |
| Recruiting |
NCT03406819 -
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
|
N/A | |
| Recruiting |
NCT05510661 -
Use of Export in Primary Percutaneous Coronary Intervention
|
N/A | |
| Completed |
NCT03146858 -
Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study
|
Phase 4 | |
| Not yet recruiting |
NCT01158846 -
Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
|
Phase 4 | |
| Active, not recruiting |
NCT03735719 -
Biomarkers for Risk Stratification After STEMI
|